Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Telmisartan Exerts Sustained Blood Pressure Control and Reduces Blood Pressure Variability in Metabolic Syndrome by Inhibiting Sympathetic Activity.

Sueta D, Koibuchi N, Hasegawa Y, Toyama K, Uekawa K, Katayama T, Ma M, Nakagawa T, Ogawa H, Kim-Mitsuyama S.

Am J Hypertens. 2014 May 28. pii: hpu076. [Epub ahead of print]

PMID:
24871627
[PubMed - as supplied by publisher]
2.

Novel mechanism for disrupted circadian blood pressure rhythm in a rat model of metabolic syndrome--the critical role of angiotensin II.

Sueta D, Kataoka K, Koibuchi N, Toyama K, Uekawa K, Katayama T, Mingjie M, Nakagawa T, Waki H, Maeda M, Yasuda O, Matsui K, Ogawa H, Kim-Mitsuyama S.

J Am Heart Assoc. 2013 Apr 29;2(3):e000035. doi: 10.1161/JAHA.113.000035.

PMID:
23629805
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Blood pressure variability, impaired autonomic function and vascular senescence in aged spontaneously hypertensive rats are ameliorated by angiotensin blockade.

Sueta D, Koibuchi N, Hasegawa Y, Toyama K, Uekawa K, Katayama T, Ma M, Nakagawa T, Waki H, Maeda M, Ogawa H, Kim-Mitsuyama S.

Atherosclerosis. 2014 Jun 26;236(1):101-107. doi: 10.1016/j.atherosclerosis.2014.06.016. [Epub ahead of print]

PMID:
25016364
[PubMed - as supplied by publisher]
4.

Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.

Nishimura T, Hashimoto J, Ohkubo T, Kikuya M, Metoki H, Asayama K, Totsune K, Imai Y.

Clin Exp Hypertens. 2005 Aug;27(6):477-89.

PMID:
16081340
[PubMed - indexed for MEDLINE]
5.

Telmisartan provides better renal protection than valsartan in a rat model of metabolic syndrome.

Khan AH, Imig JD.

Am J Hypertens. 2011 Jul;24(7):816-21. doi: 10.1038/ajh.2011.34. Epub 2011 Mar 17.

PMID:
21415842
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.

White WB, Lacourciere Y, Davidai G.

Am J Hypertens. 2004 Apr;17(4):347-53.

PMID:
15062889
[PubMed - indexed for MEDLINE]
7.

Sustained antihypertensive activity of telmisartan compared with valsartan.

Lacourcière Y, Krzesinski JM, White WB, Davidai G, Schumacher H.

Blood Press Monit. 2004 Aug;9(4):203-10.

PMID:
15311147
[PubMed - indexed for MEDLINE]
8.

Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial.

White WB, Murwin D, Chrysant SG, Koval SE, Davidai G, Guthrie R.

Blood Press Monit. 2008 Feb;13(1):21-7. doi: 10.1097/MBP.0b013e3282f3859d. Erratum in: Blood Press Monit. 2008 Aug;13(4):241.

PMID:
18199920
[PubMed - indexed for MEDLINE]
9.

Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.

Takai S, Jin D, Kimura M, Kirimura K, Sakonjo H, Tanaka K, Miyazaki M.

Hypertens Res. 2007 Dec;30(12):1231-7. doi: 10.1291/hypres.30.1231.

PMID:
18344629
[PubMed - indexed for MEDLINE]
10.

Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome.

Kishi T, Hirooka Y, Konno S, Sunagawa K.

J Hypertens. 2012 Aug;30(8):1646-55. doi: 10.1097/HJH.0b013e328355860e.

PMID:
22728908
[PubMed - indexed for MEDLINE]
11.

Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.

Galle J, Schwedhelm E, Pinnetti S, Böger RH, Wanner C; VIVALDI investigators.

Nephrol Dial Transplant. 2008 Oct;23(10):3174-83. doi: 10.1093/ndt/gfn230. Epub 2008 May 1.

PMID:
18450829
[PubMed - indexed for MEDLINE]
Free Article
12.

Effects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathy.

Masuda S, Tamura K, Wakui H, Kanaoka T, Ohsawa M, Maeda A, Dejima T, Yanagi M, Azuma K, Umemura S.

Hypertens Res. 2009 Nov;32(11):950-5. doi: 10.1038/hr.2009.131. Epub 2009 Aug 28.

PMID:
19713965
[PubMed - indexed for MEDLINE]
13.

Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.

Israili ZH.

J Hum Hypertens. 2000 Apr;14 Suppl 1:S73-86. Review.

PMID:
10854085
[PubMed - indexed for MEDLINE]
14.

The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients.

Yano Y, Hoshide S, Ishikawa J, Noguchi C, Tukui D, Takanori H, Tada M, Kanemaru Y, Yano A, Ishikawa S, Shimada K, Kario K.

Am J Hypertens. 2007 May;20(5):565-72.

PMID:
17485023
[PubMed - indexed for MEDLINE]
15.

A systematic review and meta-analysis of telmisartan versus valsartan in the management of essential hypertension.

Zheng Z, Lin S, Shi H.

J Clin Hypertens (Greenwich). 2010 Jun;12(6):414-21. doi: 10.1111/j.1751-7176.2010.00287.x. Review.

PMID:
20591086
[PubMed - indexed for MEDLINE]
16.

Long-term renal denervation normalizes disrupted blood pressure circadian rhythm and ameliorates cardiovascular injury in a rat model of metabolic syndrome.

Katayama T, Sueta D, Kataoka K, Hasegawa Y, Koibuchi N, Toyama K, Uekawa K, Mingjie M, Nakagawa T, Maeda M, Ogawa H, Kim-Mitsuyama S.

J Am Heart Assoc. 2013 Aug 23;2(4):e000197. doi: 10.1161/JAHA.113.000197.

PMID:
23974905
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension.

Marfatia R, White WB, Schumacher H.

Int J Hypertens. 2012;2012:976828. doi: 10.1155/2012/976828. Epub 2012 Jul 10.

PMID:
22844584
[PubMed]
Free PMC Article
18.

Telmisartan versus valsartan in patients with hypertension: effects on cardiovascular, metabolic, and inflammatory parameters.

Lim SY, Kim SW, Kim EJ, Kang JH, Kim SA, Kim YK, Na JO, Choi CU, Lim HE, Han SW, Rha SW, Park CG, Seo HS, Oh DJ.

Korean Circ J. 2011 Oct;41(10):583-9. doi: 10.4070/kcj.2011.41.10.583. Epub 2011 Oct 31.

PMID:
22125557
[PubMed]
Free PMC Article
19.

A meta-analysis of randomized trials of telmisartan vs. valsartan therapy for blood pressure reduction.

Takagi H, Niwa M, Mizuno Y, Goto SN, Umemoto T; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group.

Hypertens Res. 2013 Jul;36(7):627-33. doi: 10.1038/hr.2012.233. Epub 2013 Jan 24.

PMID:
23344134
[PubMed - indexed for MEDLINE]
20.

Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension.

White WB, Davidai G, Schumacher H.

J Hum Hypertens. 2009 Dec;23(12):817-25. doi: 10.1038/jhh.2009.28. Epub 2009 Apr 9.

PMID:
19357698
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk